
- Volume 0 0
Procedure May Relieve Agony of Spinal Cord Injuries
Molecular neurosurgery may someday offer pain relief to patients with spinal cord injuries. A study, reported recently in the on-line edition of Neuroscience Letters, found that a potent neurotoxin eliminated pain-transmitting rogue nerve cells that caused chronic pain in rats with paralyzing spinal cord injuries. In molecular neurosurgery, the neurotoxin acts on specific sites in the spinal cord, where the neurotoxin is incorporated into nerve cells, which then die.
The findings may help researchers better grasp the mechanisms of pain experienced by individuals after a spinal cord injury. Statistics have shown that up to 80% of individuals with spinal cord injuries develop some form of chronic pain at or below the level of paralysis.
Articles in this issue
over 21 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 21 years ago
Research Links Diabetes with Alzheimer'sover 21 years ago
Individuals with Chronic Pain Keep Quietover 21 years ago
Association Redesigns Web Siteover 21 years ago
Fibromyalgia Hits Individuals Differentlyover 21 years ago
Europeans Are Slow to Seek Treatmentover 21 years ago
Intervention Curbs Asthma in Childrenover 21 years ago
Vaccine at Birth May Diminish Allergiesover 21 years ago
Asthma in Women Is Greater with Acetaminophen Useover 21 years ago
Prediabetes Figures Are ClimbingNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.